TUE 25 JAN 3:50 PM EST -

FRI 28 JAN 3:00 PM EST

Advanced Therapies Week 2022

Hosted by: Phacilitate

TrakCel was delighted to present at the Advanced Therapies Week 2022 in the Miami Beach Convention Centre from the 25th-28th January.

Our team were on stand 309 answering questions and demonstrating both our brand new Orchestration Platform OCELLOS Lite and the exciting new integration with Fusion, the Patient Hub Services Platform from AmerisourceBergen. With a full range of services to manage your CGT Supply chain and ensure that everything runs smoothly and efficiently giving you access to accurate and real-time information in order to make critical decisions quickly.

It was a fantastic opportunity to catch up with many of our integrated partners such as AmerisourceBergen, Be The Match, BINOCS, Körber, Marken and QuickStat amongst others, as well as having some fantastic meetings with therapy developers looking to address supply chain challenges.

Our Co-founder and VP Scientific Affairs and Product Development, Dr Matthew Lakelin presented on TrakCel's exciting new product developments and the changes to the industry over the last ten years that have prompted the need to evolve cell orchestration even further to keep up with the growing complexities of new therapies. Dr Lakelin also looked at what the future holds for our suite of solutions, as therapies continue to develop rapidly, resolving challenges from first-in-human trials through to commercialisation, over a broad range of therapy types.

If you missed any of our team at the event, Dr Fiona Withey - CEO, Ravi Nalliah - CSO, Dr Matthew Lakelin - VP Scientific Affairs & Product Development, Arturo Araya - CCO, Paul Viggers - SVP Business Development or Dr Carl Taylor - CDO at the show, they would be more than happy to set up a follow up meeting to discuss your supply chain challenges, just fill out the contact details below.

    Arrange a Meeting




    Are there any specific areas that you are looking to integrate?

    Partner Ecosystem


    Tour our tomorrow, today